Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Utah Medical Products (UTMD) Short-term Investments (2010 - 2013)

Utah Medical Products' quarterly Short-term Investments came in at $47000.0 in Q1 2013, down 41.25% year-on-year from $80000.0 in Q1 2012, and up 11.9% quarter-over-quarter from $42000.0 in Q4 2012.

Utah Medical Products has reported Short-term Investments for 4 years, with the latest figure at $47000.0 in Q1 2013.

  • For the quarter ending Q1 2013, Short-term Investments fell 41.25% year-over-year to $47000.0; the trailing twelve-month figure through Mar 2013 stood at $47000.0 (down 41.25% YoY), and the FY2012 full-year result was $42000.0, down 34.38% from the prior year.
  • Short-term Investments for Q1 2013 stood at $47000.0, up from $42000.0 in the prior quarter.
  • The five-year high for Short-term Investments was $14.7 million in Q4 2010, with the low at $42000.0 in Q4 2012.
  • Average Short-term Investments over 4 years is $1.7 million, with a median of $71000.0 recorded in 2012.
  • Year-over-year, Short-term Investments sank 99.57% in 2011 and surged 39.66% in 2012.
  • Tracing UTMD's Short-term Investments over 4 years: stood at $14.7 million in 2010, then slumped by 99.57% to $64000.0 in 2011, then plunged by 34.38% to $42000.0 in 2012, then increased by 11.9% to $47000.0 in 2013.
  • The last three Short-term Investments figures came in at $47000.0 (Q1 2013), $42000.0 (Q4 2012), and $81000.0 (Q3 2012), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn
10 Utah Medical Products 204.80 Mn 117.39 Mn 5.28 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2013 47,000.00
Dec 31, 2012 42,000.00
Sep 30, 2012 81,000.00
Jun 30, 2012 71,000.00
Mar 31, 2012 80,000.00
Dec 31, 2011 64,000.00
Sep 30, 2011 58,000.00
Jun 30, 2011 83,000.00
Dec 31, 2010 14.72 Mn